Home
Conditions
Chemically-Induced Disorders

Clinical trial condition

Chemically-Induced Disorders

Explore clinical trials studying Chemically-Induced Disorders. Study availability and eligibility vary by location and protocol.

7,283 public trials 1,001 recruiting studies

Refine in advanced search Browse all conditions

Chemically-Induced Disorders trial results

Completed

REBOUND PAIN AFTER PERIPHERAL NERVE BLOCKS

NCT05635383

Conditions: Agnosia, Bites and Stings, Block, +10 more
Locations: University of Medical Science, Yıldırım Beyazıt Training and Research Hospital Ankara, Turkey (Türkiye)

Diskapi Yildirim Beyazit Education and Research Hospital Ankara, Turkey (Türkiye)

View Trial Details

Completed

Does Medical Cannabis Reduce Opioid Use in Adults With Pain

NCT04308148

Conditions: Chemically-Induced Disorders, Chronic Pain, Marijuana, +8 more
Locations: Montefiore Health System The Bronx, New York, United States

View Trial Details

Completed

THC and Ketamine Effects in Humans: Relation to Neural Oscillations and Psychosis

NCT04199468

Conditions: Cannabis, Chemically-Induced Disorders, Ketamine, +3 more
Locations: VA Connecticut Healthcare System West Haven, Connecticut, United States

View Trial Details

Completed

Acute Effects of Vaping Nicotine on Cognition in Young Adults

NCT04901208

Conditions: Behavior, Chemically-Induced Disorders, Mental Disorders, +5 more
Locations: Yale University New Haven, Connecticut, United States

View Trial Details

Completed

Adjunctive Corticosteroids for Tuberculous Meningitis in HIV-infected Adults (The ACT HIV Trial)

NCT03092817

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +24 more
Locations: Cipto Mangunkusumo Hospital Jakarta, Indonesia

Eijkman-Oxford Clinical Research Unit Jakarta, Indonesia

RSUP Persahabatan Hospital Jakarta, Indonesia

Hospital for Tropical Diseases Ho Chi Minh City, Vietnam

View Trial Details

Completed

Connection, Navigation, Engagement in Care and Treatment for Opioid Use Disorder

NCT04797962

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations: Denver Health Denver, Colorado, United States

View Trial Details

Completed

A Bioequivalence Study of 21 Milligram (mg) Nicotine Transdermal Patches (NicoDerm CQ, GlaxoSmithKline [GSK] Dungarvan) Compared to the Current Marketed 21 mg Nicotine Transdermal Patches (NicoDerm CQ, Alza) in Healthy Adult Smokers

NCT05024747

Conditions: Chemically-Induced Disorders, Mental Disorders, Substance-Related Disorders, +1 more
Locations: GSK Investigational Site Springfield, Missouri, United States

View Trial Details

Completed

Tobacco Treatment for Employable Californians, Total IMPACT Study

NCT02478697

Conditions: Behavior, Chemically-Induced Disorders, Health Behavior, +6 more
Locations: JobTrain Menlo Park, California, United States

San Francisco Employment Development Department San Francisco, California, United States

Marin Employment Connection San Rafael, California, United States

View Trial Details

Completed

Transitional Case Management for Patients Suffering From Substance Use Disorders

NCT03551301

Conditions: Chemically-Induced Disorders, Mental Disorders, Substance Use Disorders, +1 more
Locations: Service d'addictologie HUG Geneva, Switzerland

View Trial Details

Completed

Guanfacine to Improve Substance Use Outcomes in Women

NCT03980184

Conditions: Chemically-Induced Disorders, Mental Disorders, Substance Use Disorders, +1 more
Locations: The Yale Stress Center: Yale University New Haven, Connecticut, United States

View Trial Details

Chemically-Induced Disorders

Chemically-Induced Disorders trial results

Related conditions